A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
167/280
A61K 31/12 (2006.01)
Patent
CA 2001568
The present invention relates to the use of 2-[4-(4-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone or a physiologically acceptable salt or other physiologically funtional derivative thereof for the manufacture of a medicament for the treatment and/or prophylaxis of toxoplasmosis in animals, to pharmaceutical compositions for the treatment and/or prophylaxis of toxoplasmosis, comprising said compound as active ingredient and to a method of treating or preventing toxoplasmosis in an animal which comprises administering to said animal an effective amount of said compound.
La présente invention concerne l'utilisation de 2-[4-(4-chlorophényl) cyclohexyl]-3-hydroxy-1,4-naphtoquinone ou d'un sel physiologiquement acceptable ou d'un autre dérivé physiologiquement fonctionnel de cette dernière pour la fabrication d'un médicament pour le traitement et/ou la prévention de la toxoplasmose chez les animaux; l'invention concerne également des compositions pharmaceutiques pour le traitement et/ou la prévention de la toxoplasmose, comprenant ledit composé comme ingrédient actif et une méthode pour traiter ou prévenir la toxoplasmose chez un animal qui comprend l'administration audit animal d'une quantité efficace dudit composé.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Wellcome Foundation Limited (the)
LandOfFree
Medicament for treating toxoplasmosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament for treating toxoplasmosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament for treating toxoplasmosis will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1653570